Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Interest Coverage Ratio of 23.16 for Q1 2026, up 49.78% on a QoQ basis from 46.11 in Q4 2025, and up 94.85% year-over-year from 11.88 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 23.16 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 94.85% year-over-year to 23.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 90.17 (up 93.7% YoY) and the FY2025 annual result came in at 63.39, down 17815.86% from the prior year.
- Interest Coverage Ratio was 23.16 for Q1 2026 at Oramed Pharmaceuticals, up from 46.11 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 15.38 in Q4 2023 and bottomed at 520.8 in Q1 2023.
- A 5-year average of 74.17 and a median of 11.92 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 110.86% — and 2025, when it sank 8893.92%.
- Oramed Pharmaceuticals' Interest Coverage Ratio stood at 141.68 in 2022, then jumped by 110.86% to 15.38 in 2023, then tumbled by 60.26% to 6.11 in 2024, then slumped by 854.24% to 46.11 in 2025, then soared by 49.78% to 23.16 in 2026.
- Business Quant data shows ORMP's Interest Coverage Ratio at 23.16 in Q1 2026, 46.11 in Q4 2025, and 18.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -23.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.16 |
| Dec 31, 2025 | -46.11 |
| Sep 30, 2025 | -18.11 |
| Jun 30, 2025 | -18.57 |
| Mar 31, 2025 | -450.00 |
| Dec 31, 2024 | 6.11 |
| Sep 30, 2024 | -6.94 |
| Jun 30, 2024 | -12.01 |
| Mar 31, 2024 | -5.00 |
| Dec 31, 2023 | 15.38 |
| Sep 30, 2023 | -3.50 |
| Jun 30, 2023 | -4.99 |
| Mar 31, 2023 | -520.80 |
| Dec 31, 2022 | -141.68 |
| Sep 30, 2022 | -8.61 |
| Jun 30, 2022 | -11.02 |
| Mar 31, 2022 | -11.92 |
| Aug 31, 2021 | -3,027.88 |
| Nov 30, 2019 | -121.45 |
| Aug 31, 2019 | -5.68 |